Roche, Ascletis to jointly develop investigational Hepatitis-C drug in China
Roche’s investigational protease inhibitor Danoprevir is a potent Hepatitis-C Virus (HCV) therapeutic active against HCV genotypes 1 and 4. Roche Pharmaceuticals Asia Pacific head Luke Miels said, "The
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.